Champlain Investment Partners’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,687,972
| Closed | -$95.3M | – | 125 |
|
|
2024
Q1 | $95.3M | Buy |
2,687,972
+252,015
| +10% | +$10.1M | 0.55% | 74 |
|
|
2023
Q4 | $106M | Sell |
2,435,957
-2,872
| -0.1% | -$113K | 0.63% | 66 |
|
|
2023
Q3 | $93.1M | Sell |
2,438,829
-1,462,894
| -37% | -$61.5M | 0.6% | 68 |
|
|
2023
Q2 | $160M | Sell |
3,901,723
-1,269,936
| -25% | -$61.1M | 0.99% | 36 |
|
|
2023
Q1 | $297M | Sell |
5,171,659
-87,865
| -2% | -$4.95M | 1.87% | 7 |
|
|
2022
Q4 | $295M | Sell |
5,259,524
-100,031
| -2% | -$5.09M | 1.89% | 5 |
|
|
2022
Q3 | $227M | Sell |
5,359,555
-93,260
| -2% | -$4.78M | 1.55% | 10 |
|
|
2022
Q2 | $295M | Sell |
5,452,815
-132,915
| -2% | -$7.98M | 1.9% | 6 |
|
|
2022
Q1 | $359M | Sell |
5,585,730
-109,107
| -2% | -$7.18M | 1.86% | 5 |
|
|
2021
Q4 | $381M | Sell |
5,694,837
-32,400
| -0.6% | -$2.19M | 1.73% | 6 |
|
|
2021
Q3 | $392M | Sell |
5,727,237
-782,793
| -12% | -$55.3M | 1.88% | 3 |
|
|
2021
Q2 | $444M | Sell |
6,510,030
-19,145
| -0.3% | -$1.35M | 2.11% | 2 |
|
|
2021
Q1 | $451M | Buy |
6,529,175
+70,710
| +1% | +$4.79M | 2.35% | 1 |
|
|
2020
Q4 | $419M | Buy |
6,458,465
+187,445
| +3% | +$10.1M | 2.41% | 2 |
|
|
2020
Q3 | $296M | Buy |
6,271,020
+62,910
| +1% | +$2.99M | 2.01% | 5 |
|
|
2020
Q2 | $292M | Buy |
6,208,110
+8,890
| +0.1% | +$437K | 2.09% | 3 |
|
|
2020
Q1 | $277M | Buy |
6,199,220
+132,560
| +2% | +$6.96M | 2.49% | 1 |
|
|
2019
Q4 | $354M | Buy |
6,066,660
+387,900
| +7% | +$23.1M | 2.58% | 1 |
|
|
2019
Q3 | $341M | Sell |
5,678,760
-81,470
| -1% | -$4.85M | 2.81% | 1 |
|
|
2019
Q2 | $322M | Buy |
5,760,230
+286,410
| +5% | +$14.7M | 2.7% | 1 |
|
|
2019
Q1 | $305M | Buy |
5,473,820
+77,845
| +1% | +$3.96M | 2.66% | 1 |
|
|
2018
Q4 | $243M | Buy |
5,395,975
+53,390
| +1% | +$2.93M | 2.47% | 1 |
|
|
2018
Q3 | $352M | Buy |
5,342,585
+211,115
| +4% | +$13.1M | 3.12% | 1 |
|
|
2018
Q2 | $331M | Buy |
5,131,470
+133,875
| +3% | +$8.29M | 3.2% | 1 |
|
|
2018
Q1 | $277M | Buy |
4,997,595
+351,520
| +8% | +$18.4M | 2.99% | 1 |
|
|
2017
Q4 | $222M | Buy |
4,646,075
+110,355
| +2% | +$5.4M | 2.52% | 3 |
|
|
2017
Q3 | $229M | Buy |
4,535,720
+88,031
| +2% | +$4.52M | 2.7% | 1 |
|
|
2017
Q2 | $242M | Buy |
4,447,689
+8,929
| +0.2% | +$426K | 2.96% | 1 |
|
|
2017
Q1 | $187M | Buy |
4,438,760
+497,530
| +13% | +$21.3M | 2.46% | 3 |
|
|
2016
Q4 | $169M | Buy |
3,941,230
+686,032
| +21% | +$27.9M | 2.34% | 5 |
|
|
2016
Q3 | $134M | Sell |
3,255,198
-31,452
| -1% | -$1.32M | 2.04% | 6 |
|
|
2016
Q2 | $131M | Buy |
3,286,650
+287,850
| +10% | +$10.4M | 2.26% | 5 |
|
|
2016
Q1 | $101M | Buy |
2,998,800
+35,050
| +1% | +$1.09M | 1.83% | 9 |
|
|
2015
Q4 | $100M | Sell |
2,963,750
-94,730
| -3% | -$2.96M | 1.72% | 9 |
|
|
2015
Q3 | $91.1M | Sell |
3,058,480
-423,302
| -12% | -$13.2M | 1.59% | 10 |
|
|
2015
Q2 | $95.9M | Sell |
3,481,782
-28,355
| -0.8% | -$756K | 1.51% | 11 |
|
|
2015
Q1 | $88.5M | Sell |
3,510,137
-25,076
| -0.7% | -$593K | 1.51% | 15 |
|
|
2014
Q4 | $78.4M | Buy |
3,535,213
+200,806
| +6% | +$4.07M | 1.25% | 23 |
|
|
2014
Q3 | $67.7M | Sell |
3,334,407
-71,681
| -2% | -$1.43M | 1.17% | 19 |
|
|
2014
Q2 | $65.5M | Buy |
3,406,088
+39,217
| +1% | +$731K | 1.07% | 22 |
|
|
2014
Q1 | $63.3M | Sell |
3,366,871
-41,994
| -1% | -$810K | 1.09% | 23 |
|
|
2013
Q4 | $66.5M | Sell |
3,408,865
-118,519
| -3% | -$2.17M | 1.17% | 20 |
|
|
2013
Q3 | $58M | Buy |
3,527,384
+8,954
| +0.3% | +$144K | 1.1% | 29 |
|
|
2013
Q2 | $52.7M | Buy |
+3,518,430
| New | +$51.6M | 1.06% | 28 |
|
Other funds holding IART
CB
Champlain Investment Partners's IART Position: Q2 2024 in Review
Champlain Investment Partners sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 2,687,972 shares — an estimated $95.3M sold.
Champlain Investment Partners first reported a position in IART in Q2 2013 and held it in 44 quarters. The position peaked at $451M in Q1 2021. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.
- Champlain Investment Partners reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
- Champlain Investment Partners sold 2,687,972 Integra LifeSciences shares in Q2 2024, an estimated $95.3M.
- Champlain Investment Partners first reported a position in Integra LifeSciences in Q2 2013 and held it in 44 quarters.
- Champlain Investment Partners's Integra LifeSciences position peaked at $451M in Q1 2021.
- 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.
Based on Champlain Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.